Your browser is no longer supported. Please, upgrade your browser.
CDNA CareDx, Inc daily Stock Chart
CDNA [NASD]
CareDx, Inc
Index- P/E- EPS (ttm)-0.52 Insider Own2.40% Shs Outstand46.70M Perf Week-13.27%
Market Cap884.97M Forward P/E28.80 EPS next Y0.66 Insider Trans-4.44% Shs Float41.79M Perf Month-18.56%
Income-22.00M PEG- EPS next Q0.03 Inst Own98.40% Short Float12.47% Perf Quarter-7.74%
Sales127.10M P/S6.96 EPS this Y60.30% Inst Trans0.03% Short Ratio6.17 Perf Half Y-25.57%
Book/sh2.33 P/B8.13 EPS next Y311.25% ROA-15.50% Target Price45.00 Perf Year-31.71%
Cash/sh0.82 P/C23.17 EPS next 5Y20.00% ROE-22.80% 52W Range13.04 - 41.27 Perf YTD-12.15%
Dividend- P/FCF- EPS past 5Y-52.30% ROI-22.80% 52W High-54.08% Beta0.92
Dividend %- Quick Ratio1.90 Sales past 5Y36.00% Gross Margin64.20% 52W Low45.32% ATR2.52
Employees306 Current Ratio2.10 Sales Q/Q52.30% Oper. Margin-19.30% RSI (14)45.58 Volatility11.14% 13.83%
OptionableYes Debt/Eq0.00 EPS Q/Q-20.30% Profit Margin-17.30% Rel Volume0.52 Prev Close20.64
ShortableYes LT Debt/Eq0.00 EarningsFeb 27 AMC Payout- Avg Volume843.93K Price18.95
Recom1.60 SMA20-2.79% SMA50-15.94% SMA200-23.62% Volume436,053 Change-8.19%
Oct-01-19Resumed Craig Hallum Buy $48
May-09-19Upgrade H.C. Wainwright Neutral → Buy $30 → $43
Feb-15-19Initiated Jefferies Buy $35
Oct-23-18Resumed Raymond James Strong Buy $30
Sep-18-18Reiterated H.C. Wainwright Neutral $17 → $22
Nov-27-17Initiated H.C. Wainwright Buy $12
Jun-14-16Reiterated Mizuho Buy $12 → $8
Sep-29-15Downgrade Raymond James Outperform → Mkt Perform
Sep-25-15Initiated Craig Hallum Buy
Mar-18-15Reiterated Mizuho Buy $15 → $12
Apr-02-20 06:44AM  Is There An Opportunity With CareDx, Inc's (NASDAQ:CDNA) 54% Undervaluation? Simply Wall St. +6.06%
Mar-25-20 12:46AM  Edited Transcript of CDNA earnings conference call or presentation 27-Feb-20 9:30pm GMT Thomson Reuters StreetEvents +13.21%
Mar-20-20 07:00AM  REPEAT - New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy GlobeNewswire +6.97%
01:05AM  New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy GlobeNewswire
Mar-17-20 10:10AM  Are Options Traders Betting on a Big Move in CareDx (CDNA) Stock? Zacks -6.36%
08:48AM  The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment Benzinga
07:00AM  CareDx Launches RemoTraC: Home-Based Monitoring of Transplant Patients GlobeNewswire
Mar-12-20 07:00AM  CareDx Joins National Kidney Foundation on World Kidney Day to Support Kidney Transplant Community GlobeNewswire -10.22%
Mar-05-20 07:00AM  CareDx Brings Personalized Care to Transplant with the Launch of KIRA Immuno-optimization Study at CEOT GlobeNewswire
Feb-28-20 07:00AM  CareDx to Participate in Upcoming Investor Conferences GlobeNewswire
Feb-27-20 04:05PM  CareDx Reports Fourth Quarter and Full Year 2019 Results GlobeNewswire -9.09%
06:11AM  Does CareDx, Inc's (NASDAQ:CDNA) CEO Salary Compare Well With Others? Simply Wall St.
Feb-26-20 07:00AM  New AJT Publication: AlloSure is the Only cfDNA Test Proven to Differentiate Ambiguous Rejections GlobeNewswire
Feb-20-20 12:31PM  CareDx (CDNA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Feb-19-20 11:18AM  The Zacks Analyst Blog Highlights: Smith Micro Software, Accuray, Vista Outdoor, Synaptics and CareDx Zacks
Feb-18-20 08:47AM  Trump Mulling Tax Cuts to Incentivize Stock Buying? 6 Picks Zacks
Feb-13-20 07:00AM  CareDx to Report Fourth Quarter and Full Year 2019 Financial Results on February 27, 2020 GlobeNewswire
Feb-11-20 07:00AM  CareDxs Patent Rights Upheld By Delaware Court GlobeNewswire
Feb-07-20 12:00PM  CareDx (CDNA) Upgraded to Strong Buy: Here's Why Zacks -5.07%
Feb-06-20 09:16AM  US Service Sector Accelerates in January: 5 Stocks to Buy Zacks
Feb-04-20 08:15AM  The Zacks Analyst Blog Highlights: Calavo Growers, Darling Ingredients, The Simply Good Foods Company, KalVista Pharmaceuticals and CareDx Zacks
07:00AM  CareDx Launches AiTraC Conference GlobeNewswire
Feb-03-20 11:54AM  5 Defensive Stocks to Counter Coronavirus Scare Zacks
06:55AM  Super Bowl Results Show Stock Gains in February: 5 Picks Zacks
Jan-22-20 04:44PM  Teladoc (TDOC) Hits 52-Week High: Will Momentum Sustain? Zacks
06:15AM  When Will CareDx, Inc (NASDAQ:CDNA) Breakeven? Simply Wall St.
Jan-13-20 07:00AM  CareDx Reports Preliminary Fourth Quarter and Full Year 2019 Results GlobeNewswire +13.33%
Jan-10-20 07:00AM  CareDxs AlloSeq cfDNA Awarded CE Mark Approval GlobeNewswire
Jan-09-20 07:00AM  CareDx Leadership at ASTS Meeting GlobeNewswire
Jan-08-20 07:00AM  CareDx's False Advertising Complaint Upheld By Court GlobeNewswire
Dec-24-19 07:00AM  CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Dec-23-19 02:38PM  CareDx Supports Bipartisan Legislation to Protect Kidney Transplant Patients GlobeNewswire
Dec-17-19 05:28AM  Should You Be Concerned About CareDx, Inc's (NASDAQ:CDNA) Historical Volatility? Simply Wall St.
Dec-07-19 12:26PM  Is CareDx, Inc. (CDNA) A Good Stock To Buy? Insider Monkey
Nov-19-19 07:00AM  CareDx to Participate in Upcoming Investor Conferences GlobeNewswire
Nov-11-19 08:36AM  Did The Underlying Business Drive CareDx's (NASDAQ:CDNA) Lovely 417% Share Price Gain? Simply Wall St.
Nov-06-19 12:19PM  Edited Transcript of CDNA earnings conference call or presentation 31-Oct-19 8:30pm GMT Thomson Reuters StreetEvents
07:00AM  CareDx at ASN Kidney Week GlobeNewswire
Nov-04-19 07:00AM  CareDx Advances Patient Care with AlloSure 3.0 GlobeNewswire -10.26%
Nov-01-19 09:00AM  All You Need to Know About CareDx (CDNA) Rating Upgrade to Strong Buy Zacks -11.90%
07:38AM  The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance Benzinga
Oct-31-19 04:05PM  CareDx Reports Third Quarter 2019 Results GlobeNewswire
Oct-26-19 12:48PM  Were Hedge Funds Right About Flocking Into CareDx, Inc. (CDNA)? Insider Monkey
Oct-18-19 10:09AM  Top Ranked Momentum Stocks to Buy for October 18th Zacks
Oct-17-19 08:00AM  CareDx to Announce Third Quarter 2019 Financial Results on October 31st, 2019 GlobeNewswire
Oct-12-19 09:25AM  We're Excited To See How CareDx (NASDAQ:CDNA) Uses Its Cash Hoard To Grow Simply Wall St.
Oct-07-19 10:20AM  CareDx, Inc (CDNA) Shares March Higher, Can It Continue? Zacks
Sep-26-19 09:25AM  CareDx Files Patent Infringement Lawsuit Against Eurofins Viracor GlobeNewswire
Sep-24-19 08:00AM  CareDx Adds HistoMap To Testing Portfolio GlobeNewswire -5.60%
Sep-23-19 08:00AM  CareDxs KidneyCare iBox Technology Clinically Validated in BMJ Publication GlobeNewswire
Sep-20-19 08:00AM  CareDx Launches AlloSeq® Tx 17 at ASHI/BANFF Meeting GlobeNewswire
Sep-18-19 08:00AM  First Patient Enrolled in Landmark CareDx OKRA Registry GlobeNewswire
Sep-17-19 08:00AM  CareDx to Participate in the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-12-19 08:00AM  CareDx launches AlloSeq® cfDNA at ESOT 2019 GlobeNewswire +7.44%
07:41AM  Who Has Been Selling CareDx, Inc (NASDAQ:CDNA) Shares? Simply Wall St.
Sep-11-19 04:01PM  CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Aug-28-19 08:00AM  CareDx Acquires XynManagement GlobeNewswire
Aug-27-19 08:00AM  Chris Cournoyer Joins CareDx Board of Directors GlobeNewswire
Aug-22-19 09:48AM  AlloSure for Heart Transplant Patients Receives CMS Draft Coverage GlobeNewswire
Aug-21-19 08:00AM  Fear of Rejection is Transplant Patients Top Concern GlobeNewswire
Aug-09-19 01:45PM  CDNA INVESTIGATION ALERT: Bernstein Liebhard LLP Reminds Investors of Its Investigation of CareDx Inc.- CDNA ACCESSWIRE -8.39%
Aug-08-19 07:16PM  Caredx Inc (CDNA) CEO Peter Maag Sold $1.4 million of Shares GuruFocus.com
Aug-05-19 09:30PM  Bragar Eagel & Squire, P.C. is Investigating CareDx, Inc. (NASDAQ: CDNA) on Behalf of Stockholders and Encourages CareDx Investors to Contact the Firm GlobeNewswire -12.40%
11:40AM  Edited Transcript of CDNA earnings conference call or presentation 1-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
06:06AM  Is CareDx, Inc's (NASDAQ:CDNA) CEO Salary Justified? Simply Wall St.
Aug-03-19 09:15AM  INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. Business Wire
Aug-02-19 01:31AM  CareDx, Inc (CDNA) Q2 2019 Earnings Call Transcript Motley Fool
Aug-01-19 04:01PM  CareDx Reports Second Quarter 2019 Results GlobeNewswire
Jul-30-19 08:10PM  CDNA INVESTIGATION REMINDER: Hagens Berman Reminds CareDx (CDNA) Investors to Investigation of Possible Disclosure Violations ACCESSWIRE
12:32PM  CDNA INVESTIGATION ALERT: Bernstein Liebhard LLP Reminds Investors of Its Investigation of CareDx Inc. CDNA GlobeNewswire
11:44AM  CAREDX INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In CareDx, Inc. To Contact The Firm GlobeNewswire
Jul-26-19 05:25PM  Lifshitz & Miller LLP Announces Investigation of Amneal Pharmaceuticals, Inc., CareDx, Inc., Casa Systems, Inc., India Globalization Capital, Inc., Just Energy Group Inc., LegacyTexas Financial Group, Inc., Maxar Technologies Inc., and Unum Group PR Newswire
Jul-25-19 10:34AM  CareDx (CDNA) Reports Next Week: Wall Street Expects Earnings Growth Zacks -5.12%
Jul-24-19 07:07PM  CAREDX INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In CareDx, Inc. To Contact The Firm PR Newswire
Jul-23-19 12:29PM  CDNA INVESTIGATION ALERT: Bernstein Liebhard LLP Reminds Investors of Its Investigation of CareDx Inc. CDNA GlobeNewswire
Jul-22-19 09:00PM  Glancy Prongay & Murray LLP Continues Investigation on Behalf of CareDx, Inc. Investors (CDNA) Business Wire
06:22PM  INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of CareDx, Inc. Investors (CDNA) Business Wire
Jul-17-19 09:30PM  Bragar Eagel & Squire, P.C. Is Investigating Hibbett Sports, Pintec Technology, CareDX, and Ideanomics on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
03:18PM  CDNA INVESTIGATION ALERT: Bernstein Liebhard LLP Announces Investigation of CareDx Inc.-- CDNA PR Newswire
Jul-16-19 08:03PM  CDNA INVESTIGATION ALERT: Hagens Berman Alerts CareDx (CDNA) Investors to Investigation of Possible Disclosure Violations PR Newswire -12.91%
04:51PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) Business Wire
04:09PM  Here's Why CareDx Stock Is Sliding Today Motley Fool
01:51PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) Business Wire
Jul-11-19 08:00AM  CareDx Applauds White House Efforts to Reform Americas Kidney Health System GlobeNewswire
04:50AM  CareDx Looks Like It Can Continue Its Impressive Rally, So Go Long TheStreet.com
Jul-10-19 05:32PM  Trump's Kidney Disease Executive Order May Boost This Health Stock, Tank Others Zacks
Jul-09-19 10:00AM  What You Must Know About CareDx, Inc's (NASDAQ:CDNA) Beta Value Simply Wall St. +9.01%
Jul-02-19 08:00AM  Grace Colón succeeds Amy Abernethy on the CareDx Board GlobeNewswire
Jun-27-19 08:00AM  CareDx Supports Momentum in Medicare Immunosuppressive Medication Legislation GlobeNewswire
Jun-26-19 08:00AM  US Patent Office Issues New Transplant Patent to CareDx GlobeNewswire
Jun-19-19 06:51PM  Hedge Funds Have Never Been This Bullish On CareDx, Inc. (CDNA) Insider Monkey
Jun-10-19 08:00AM  CareDx to Participate in Upcoming Conferences GlobeNewswire
Jun-03-19 01:55PM  Is CareDx, Inc (NASDAQ:CDNA) Trading At A 41% Discount? Simply Wall St.
May-29-19 08:00AM  CareDx Announces KidneyCare and Showcases Leadership in Transplantation at ATC GlobeNewswire
May-22-19 08:36AM  CareDx to Participate in Upcoming Conferences GlobeNewswire
May-16-19 07:01PM  Edited Transcript of CDNA earnings conference call or presentation 8-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-14-19 08:33AM  CareDx applauds HHS Report on Cost Savings of Lifetime Immunosuppressive Drug Coverage for Transplant Patients GlobeNewswire
May-09-19 12:14PM  Here's Why CareDx Stock Is Rising Today Motley Fool +12.86%
May-08-19 09:48PM  CareDx, Inc (CDNA) Q1 2019 Earnings Call Transcript Motley Fool
06:45PM  CareDx (CDNA) Q1 Earnings and Revenues Top Estimates Zacks
CareDx, Inc., a precision medicine company, together with its subsidiaries, discovers, develops, and commercializes healthcare solutions for transplant patients and caregivers worldwide. The company develops a diagnostic surveillance testing solution for kidney and heart transplant recipients. It offers AlloSure, a donor-derived cell-free DNA solution for kidney transplant patients; and AlloMap, a heart transplant molecular test. The company also develops, manufactures, markets, and sells products that increase the chance of successful transplants by facilitating a match between a donor and a recipient of stem cells and solid organs. In addition, it sells Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence-specific primer technology; Olerup SBT; QTYPE that enables speed and precision in HLA typing at a low to intermediate resolution for samples that require a fast turn-around-time and uses real-time polymerase chain reaction methodology; and TruSight HLA, a high resolution solution that uses next generation sequencing methodology. Further, the company provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Ottr, a transplant patient tracking software; and XynQAPI and Waitlist Management solutions. It offers its products directly to customers, as well as through third-party and sub-distributors. The company has a license agreement with Illumina for the development, commercialization, and distribution of NGS product line for use in transplantation diagnostic testing; and Cibiltech to commercialize KidneyCare iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Maag PeterChief Executive OfficerMar 16Sale17.3910,000173,873489,909Mar 16 08:48 PM
SNYDERMAN RALPHDirectorMar 03Option Exercise3.7014,59853,99879,901Mar 04 08:37 PM
Maag PeterChief Executive OfficerFeb 18Sale26.6210,000266,201451,909Feb 19 07:25 PM
King SashaChief Commercial OfficerFeb 14Sale26.017,390192,22148,502Feb 14 09:15 PM
Maag PeterChief Executive OfficerJan 15Sale23.1310,000231,300429,814Jan 16 08:16 PM
King SashaChief Commercial OfficerDec 09Sale21.972,12646,70848,709Dec 10 06:28 PM
HAGSTROM WILLIAM ADirectorDec 03Sale20.0612,500250,76115,385Dec 05 08:22 PM
Maag PeterChief Executive OfficerAug 06Sale28.8450,0001,441,834339,814Aug 08 04:10 PM
Cohen Fred EDirectorJul 11Option Exercise6.9615,765109,67271,279Jul 15 04:27 PM
King SashaChief Commercial OfficerJul 01Option Exercise1.0025025057,877Jul 01 09:26 PM
Yee James PChief Medical OfficerJul 01Option Exercise2.3019,87545,71362,045Jul 01 09:24 PM
King SashaChief Commercial OfficerJul 01Sale35.749,542341,04548,335Jul 01 09:26 PM
Yee James PChief Medical OfficerJul 01Sale35.6520,000712,93642,045Jul 01 09:24 PM
King SashaChief Commercial OfficerJun 20Option Exercise10.4916,195169,81688,467Jun 21 05:08 PM
Bell Michael BrianChief Financial OfficerJun 20Option Exercise10.9914,702161,59485,602Jun 21 05:07 PM
Bell Michael BrianChief Financial OfficerJun 20Sale38.8114,702570,60170,900Jun 21 05:07 PM
King SashaChief Commercial OfficerJun 20Sale38.3830,8401,183,51357,627Jun 21 05:08 PM
Yee James PChief Medical OfficerJun 17Option Exercise6.4920,000129,80062,170Jun 18 07:02 PM
Yee James PChief Medical OfficerJun 17Sale37.5420,000750,87642,170Jun 18 07:02 PM
HAGSTROM WILLIAM ADirectorJun 04Sale32.3515,000485,25025,272Jun 04 09:35 PM
Bell Michael BrianChief Financial OfficerMay 20Option Exercise3.912,2028,59979,299May 22 06:05 AM
Bell Michael BrianChief Financial OfficerMay 20Sale32.102,20270,69477,097May 22 06:05 AM
Maag PeterChief Executive OfficerMay 13Sale31.1180,0002,488,496408,406May 13 09:29 PM
Bell Michael BrianChief Financial OfficerMay 09Option Exercise3.902,2018,59391,991May 13 04:21 PM
Bell Michael BrianChief Financial OfficerMay 09Sale32.4214,894482,88477,097May 13 04:21 PM
King SashaChief Commercial OfficerMay 03Option Exercise6.041,2507,54677,844May 03 08:58 PM
King SashaChief Commercial OfficerMay 03Sale29.501,25036,87576,594May 03 08:58 PM
Maag PeterSee RemarksApr 17Option Exercise2.7650,000137,854488,406Apr 18 07:52 PM
King SashaChief Commercial OfficerApr 12Option Exercise5.1112,70764,92086,594Apr 12 07:48 PM
King SashaChief Commercial OfficerApr 12Sale29.8110,000298,06476,594Apr 12 07:48 PM
Maag PeterSee RemarksApr 12Sale29.11100,0002,910,530438,406Apr 12 07:48 PM
Maag PeterSee RemarksApr 09Option Exercise5.8380,000466,587538,406Apr 09 09:43 PM